Latest News

As the countdown to the World Vaccine Congress in Washington continues with only days to go, we are ...

After experts called for “transformational change” to the “epidemic countermeasures ecosystem”, our interest has been drawn to The Vaccine ...

After a meeting in March 2023, WHO’s Strategic Advisory Group of Experts on Immunisation (SAGE) revised the roadmap ...

A study published in Nature Medicine in March explores the factors associated with so-called “vaccine fatigue”, with a ...

In March 2023 the heads of the Quadripartite organisations working on One Health issued a call for greater ...

In March 2023 the CDC commented on data that revealed an “alarming” spread of the emerging fungus Candida ...

A study released in iScience suggests that COVID-19 infection was a greater factor than COVID-19 vaccination in observed changes ...

After we reported in March 2023 that possibly critical data concerning the Huanan Seafood Wholesale Market had been ...

Just under a month after the confirmation of an outbreak of Marburg virus disease (MVD) in Equatorial Guinea, ...

A study in Microbiology Spectrum in March 2023 demonstrated the benefits of an oral vaccine for COVID-19 that ...

On Friday 24th March 2023 the WHO and other organisations and individuals observe ‘World Tuberculosis Day’ with the ...

In a study published in Nature Communications, researchers investigate the socioeconomic benefits of a set of “idealised” vaccine ...

In March 2023 the board of directors at CSPC Pharmaceutical Group Limited announced that the company’s COVID-19 mRNA ...

Africa CDC has confirmed that the Ministry of Health of the Republic of Tanzania declared an outbreak of ...

Vaxxinity announced that the first subjects of a Phase I trial had been dosed. The trial of VXX-401 ...

In March 2023, Vaccitech announced top-line interim data from a Phase Ib/II clinical trial of its VTP-200 vaccine ...

SpyBiotech, a biotechnology company spin out from the University of Oxford, announced in March 2023 that it had ...

With just weeks to go until the World Vaccine Congress in Washington, we are delighted to share our ...

In March 2023, RVAC Medicines and the University of Pennsylvania (Penn) announced a collaboration to pursue the development ...

In March 2023 new metagenomics data and SARS-CoV-2 sequences appeared on GISAID and were available to researchers across ...

The Global Polio Eradication Initiative (GPEI) and WHO Africa confirmed that cases of circulating vaccine-derived poliovirus type 2 ...

A study published in PLOS Medicine in March 2023 suggests that the human and financial benefits of a ...

In March 2023 WHO Africa reported that the Ugandan Ministry of Health is planning to vaccinate over 1.9 ...

South Korean chemical company LG Chem announced in March 2023 that it will supply essential vaccines for infants ...

In March 2023 GSK announced positive headline results from a Phase III trial evaluating its MenABCWY combination vaccine ...

Writing in The Lancet in March 2023, public health experts called for “ambitious, transformational change” to the “epidemic ...

With just weeks to go until the World Vaccine Congress in Washington this April, we are delighted to ...

Tuberculosis is one of the leading infectious causes of morbidity and mortality across the world. In 2020 it ...

A study published in Current Biology suggests that getting sufficient sleep in the days surrounding vaccination is key ...

We are pleased to share the organisations and individuals who have progressed to the final shortlist for the ...

Researchers at Tel Aviv University and the Israel Institute for Biological Research announced that they have developed an ...

Carrie Arnold explores cell-free processes and a “growing number of biomanufacturing firms” that are “embracing” a cell-free biosynthesis ...

Researchers in France published a paper in Nature Communications in March detailing the results of an investigation into ...

As we continue our countdown to the World Vaccine Congress in Washington we are delighted to share conversations ...

Just after Pfizer announced that the Vaccines and Related Biological Products Advisory Committee had voted on its RSV ...

In 2023, a few days after the FDA requested further studies into the link between GBS and its ...

With just two months until the World Vaccine Congress we are delighted that some of our wonderful speakers ...

After the news of the death of a child from avian influenza A (H5N1) in Cambodia in February ...

Just months after the conclusion of an outbreak of Marburg, the Ghana Health Service has issued a statement ...

Following the announcement of an outbreak of Marburg virus in Equatorial Guinea in February 2023, WHO has issued a ...

Following the FDA’s acceptance for review for Pfizer’s respiratory syncytial virus (RSV) vaccine candidate, the agency has asked ...

Researchers at the University of Queensland are pursuing an experimental vaccine to tackle a venereal disease that “causes ...

A study in Midwifery in February 2023 examines the quality of maternal vaccination information available in pregnancy to ...

With growing concern at the increasing cases of avian influenza in mammals across the world, the spread has ...

After an update from WHO in November 2022 that almost 40 million children are “dangerously susceptible” to measles, ...

In February 2023 LinKinVax announced positive interim results from the ANRS VRI06 Phase I trial, evaluating a preventative ...

Following positive results from a Phase IIb trial in December 2022, Moderna and Merck have announced that their ...

The complex process of vaccinating pigs is time consuming and requires direct interaction between humans and animals, or ...

The University of Queensland, Australia, announced in February 2023 that a university-led research effort had secured almost $8 ...

An article in npj vaccine in February 2023 explores the role of squalene in vaccine development and how ...

In February 2023, at a meeting of the African Union in Addis Ababa, African Heads of State agreed ...

As we get closer to the World Vaccine Congress in Washington our introductions to the start-up zone continue! ...

In February 2023 WHO announced a collaboration with Montenegro’s Ministry of Health and Institute of Public Health (IPH) ...

BactiVac, the Bacterial Vaccines Network, announced it had secured £1 million in funding from Wellcome to “accelerate the ...

In February 2023 Scancell announced completion of a monotherapy dose finding arm of the Phase I/II ModiFY clinical ...

Dr Jean Kaseya was announced the new Director General of Africa CDC at the African Union summit in ...

A paper published in February 2023 examines the results of a study investigating how a person’s housing situation ...

Pfizer, study sponsor of the VALOR Phase III clinical study, has decided to “discontinue a significant percentage of ...

Harvard T.H. Chan School of Public Health announced a new and “highly adaptable” vaccine platform with potential applications ...

Next up in our series of interviews in preparation for the Congress are our speakers from US BIOLOGIC: ...

In February 2023 Moderna announced interim results from its Phase III safety and immunogenicity trial of mRNA-1010 (P301). ...

CEPI announced that it was supporting development of an international antibody standard against Sudan ebolavirus (SUDV) following the ...

During a meeting of the IHR Emergency Committee in February 2023 on the mpox outbreak, the current infection ...

Gritstone bio and NCI announce a collaboration to evaluate an “autologous T cell therapy expressing a T cell ...

In February 2023 VBI Vaccines announced interim data evaluating a combination treatment of VBI-2601 and BRII-835 in chronically ...

After it was suggested that WHO had abandoned plans to continue the investigation into the origins of COVID-19, ...

In our discussions at the World Vaccine Congress and in published posts we continue to explore the meaning ...

WHO has “quietly shelved the second phase” of the “much-anticipated scientific investigation” into the origins of the COVID-19 ...

In February 2023 Bavarian Nordic announced that it has entered into an agreement with Emergent BioSolutions to acquire ...

With just 7 weeks until the World Vaccine Congress in Washington in April we are still announcing the ...

In February 2023 Vaxart announced that it had dosed its first subject in the Phase II clinical trial ...

In February 2023 Novavax and the US Department of Health and Human Services (HHS) announced a modification to ...

In February 2023, WHO Africa confirmed that Equatorial Guinea had announced an outbreak of Marburg virus disease following ...

In February 2023 Gavi announced the conclusion of a process that had begun in 2021: appointing a CEO ...

A report in Nature Human Behaviour in February 2023 examines reporting oversights in examining the factors behind vaccine ...

Researchers from the University of Oxford announced in February 2023 that they had developed a new diagnostic test ...

In February 2023 SK bioscience announced its intention to establish the ‘Songdo Global Research & Process Development Centre ...

In a paper published in Frontiers in Immunology in February 2023, researchers review the challenges associated with the ...

With reports of avian flu sweeping through other mammals across the world, concern is growing about the threat ...

In findings published in Jama Pediatrics in February 2023 a CDC study revealed that the maternal Tdap vaccine ...

With just under 10 weeks to go until the World Vaccine Congress in Washington we are already getting ...

The United Nations Environment Programme released a report in 2023 that addresses the role of the environment in ...

Gerresheimer AG and Corning Incorporated announced in February 2023 that they were collaborating to “increase global access to ...

Between 7th and 9th February 2023 30 partner organisations came together to participate in the first Biomanufacturing Workforce Development ...

In February 2023 Takeda UK Ltd. announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) had ...

As excitement builds for the World Vaccine Congress in Washington this April we are pleased to share a ...

Professor Deborah Fuller, writing for The Conversation in February 2023, states that “for everything there is a season, ...

In research from GlobalData in December 2022, 13 of the top 20 pharmaceutical companies saw increases in market ...

In February 2023 the World Bank Pandemic Fund announced $300 million for a first round of funding to ...

In February 2023 the UK Animal and Plant Health Agency (APHA) announced that field trials for a cattle ...

Research in The Lancet Microbe in February 2023 presents a positive update from an NIH group with their ...

As we continue preparations for the World Vaccine Congress in Washington this April we are delighted to share ...

After reports of an outbreak of HPAI in minks from a farm in Spain, updates from the UK ...

In February 2023 CEPI announced a partnership with 20Med to advance the development of 20Med’s bioresponsive polymeric nanoparticle ...

At the first ministerial meeting of the Global Alliance to end AIDS in children, leaders from African countries ...

In December 2022 the International Vaccine Access Centre was able to conduct a test run of its newly ...

Of the many lessons that we are endeavouring to learn from the COVID-19 pandemic, the importance of uniting ...

In research published in Nature biomedical engineering a team of scientists at Northwestern University’s IIN explored the effects ...

Following our previous posts, moving through the start-up zone at the World Vaccine Congress in Washington at speed, ...

Moderna announced in January 2023 that its investigational mRNA vaccine candidate for RSV, mRNA-1345, has been granted Breakthrough ...

In January 2023 IAVI released a white paper after a meeting between global health experts.  As a result ...

A study in The Lancet with NIH funding reported that a vaccine candidate against Marburg virus (MARV) was ...

The 14th meeting of the International Health Regulations (IHR) Emergency Committee regarding COVID-19 took place on Friday 27th ...

On 30th January 2023, WHO released a progress report on neglected tropical diseases (NTD) to coincide with World ...

Swiss based AC Immune reported in January 2023 that ACI-24.060, its anti-amyloid-beta (Abeta) vaccine, had “elicited an anti-Abeta ...

Moving into another year of emergence from the COVID-19 pandemic, with vaccines continuing to be a core tool ...

In January 2023 Gavi announced a delivery of vehicles and technological goods to the Government of Sierra Leone ...

As exciting as the rush around ChatGPT is, many of us may be (understandably) concerned about the implications ...

The UK government established the Life Sciences Vision in July 2021 with the ambition of creating a competitive ...

Following our previous post, in which we introduced the C-E of our start-up zone for the Congress in ...

With just 10 weeks to go before the World Vaccine Congress in Washington, we are delighted to share ...

In January 2023 the WHO launched its 2023 health emergency appeal to support millions of people around the ...

As Cervical Cancer Prevention Week starts on 23rd January 2023, the UKHSA report on routine adolescent HPV immunisation ...

In its first pipeline review of its 15 member companies, Vaccines Europe explores the 100 vaccine candidates in ...

A report by European researchers details an outbreak of highly pathogenic avian influenza detected in “intensively farmed minks ...

In January 2023 LinKinVax and Gustave Roussy announced a collaboration towards a first-in-human Phase I/IIa clinical trial on ...

A report from the Global Healthy Living Foundation (GHLF) and the IQVIA Institute revealed an increase in people ...

In January 2023 CEPI and the Institut Pasteur de Dakar (IPD) announced a 10-year partnership to “advance equitable ...

In January 2023 results in The Lancet from a network led by the Oxford Maternal and Perinatal Health ...

In January 2023 Janssen and global partners announced the results of an “independent, scheduled data review” of a ...

Just months after the announcement that Pfizer, and later GSK, had strong results in trials for RSV vaccines, ...

At a WEF panel on TB in January 2023, WHO Director-General Dr Tedros Adhanom Ghebreyesus announced intentions to ...

In January 2023 CEPI announced that it would provide up to $4.3 million (AUD6.4 million) to Vaxxas, to ...

EnsiliTech, a British-based biopharmaceutical company, announced in January 2023 that it had raised £1.2 million in pre-seed funding ...

In January 2023 Intravacc announced that the intranasal gonorrhoea candidate vaccine it is developing in partnership with Therapyx ...

In a statement published in January 2023 the US CDC and FDA indicated that CDC’s VSD “met the ...

Writing for STAT in January 2023 Dr Jerome Kim warned that the world was not learning from pandemic ...

A study in Nature Neuroscience explores the role of COVID-19 infection on the brain and demonstrates that the ...

Just four months after the declaration of an outbreak of the Sudan strain of Ebola in Uganda the ...

The Wellcome Sanger Institute in Cambridge, UK, announced a new initiative in January 2023 to improve our understanding ...

In a white paper from ICON in January 2023 the importance of preparing strong vaccines for future infectious ...

With the success of our previous post introducing the A-B of our Washington start-up zone we are delighted ...

In an article published in Nature Communications in January 2023, researchers from the US explored the importance of ...

The UN IGME released estimates in January 2023 that revealed that approximately 5 million children died before their ...

As China continues to extract itself from its former COVID-19 policies CanSino Biologics announced in January that it ...

In January 2023 the International Vaccine Institute (IVI) and Batavia Biosciences signed a Memorandum of Understanding to “promote ...

With just a few months to go before the Congress in Washington our start-up zone is already filling ...

In January 2023 BioNTech announced that it had signed a Memorandum of Understanding (MoU) with the UK government ...

As we count down until the World Vaccine Congress in Washington in April, we are looking forward to ...

In findings from Brigham and Women’s Hospital published in Science Translational Medicine, researchers reveal newly discovered potential to ...

In January 2023 Dalan Animal Health announced that the USDA had granted a conditional license for vaccination of ...

Here at VaccineNation we are delighted to kickstart the new year with another one of our recorded interviews ...

Towards the end of 2022 we noted the positive results of a Moderna/Merck trial for a personalised cancer ...

As COVID-19 continues to circulate across much of the world, China is feeling the effects of an insecure ...

Amid a surge of cholera cases in Haiti the Pan-American Health Organization (PAHO) reported in December 2022 that ...

In an article in Science in December 2022 the fate of COVAX, the “vaccines pillar” of the Access ...

In an article published in Nature Medicine in December, Professor Bergstrom highlights the responsibility of authors to “provide ...

In an article in Nature in December 2022 Dr Seth Berkley, CEO of Gavi, explored the failings of ...

The FIFA World Cup in 2022 has had its fair share of controversy, but as the competition continues ...

In December 2022 Moderna and Merck announced positive results from a Phase IIb trial of mRNA-4157/v940, an investigational ...

In an announcement on 12 December 2022, Aspen revealed that it would receive $30 million from the Gates ...

With the tragic news of the deaths of 15 children in England from strep A infection, researchers are ...

Just days after reports that the final case of Ebola had been declared in Uganda, casting doubt on ...

Research published in Nature Communications in December 2022 suggests that vaccination at different stages of a mouse’s circadian ...

As positive news from Uganda emerges that no new cases of Ebola have been identified concerns about the ...

In recent research approximately one third of children who were exposed to Zika virus before birth “developed neurological ...

Amidst widely reported protests and unrest at the continuation of a stringent zero-COVID strategy, China has admitted that ...

Valneva published a report in December 2022 that detailed positive antibody persistence data a year after vaccination with ...

In December 2022 The Vaccine Group (TVG) reported that a DARPA funded project against Lassa fever had been ...

During the COVID-19 pandemic immunisation of infants has been a highly contentious and confusing issue. From initial advice ...

On 1st December 2022 Pfizer and Valneva reported antibody persistence data 6 months after vaccination with their Lyme ...

During a meeting between Acting Director General of Africa CDC, and KDCA Commissioner it was announced that the ...

In November 2022 HDT Bio Corp. and the University of Texas Medical Branch (UTMB) revealed that they had ...

1st December 2022 is World AIDS Day, with global communities observing it under the theme “equalise”. This year, ...

White House issued a statement indicating the intention of the Biden-Harris Administration to continue to “prioritise global health ...

PharmaJet announced that it had received an NIH grant towards their Phase II investigation of the immunogenicity of ...

The WHO announced in November that the Ministry of Food and Drug Safety (MFDS), Republic of Korea, achieved ...

In November 2022 CEPI announced an investment of U$5.7 million towards the development of a second-generation molecular clamp ...

The WHO announced in November 2022 that, after “consultations with global experts”, it will begin using a preferred ...

With the World Vaccine and Immunotherapy Congress just days away we are delighted to share another exclusive interview ...

The UK government announced in November 2022 that it would be introducing a “Vaccine Taskforce style approach” to ...

In November 2022 it was reported that a child, around the age of 6, had died after catching ...

A study published in Science in November 2022 has given experts in the UK reason to predict that ...

The WHO announced that almost 40 million children were “dangerously susceptible” to the “growing threat” of measles following ...

A research paper published in Science Advances suggests the possibility of UTI prevention through a sublingual vaccine. The ...

Dementia is described by the NHS as a syndrome associated with an “ongoing decline of brain functioning”. This ...

As we gear up towards the World Vaccine and Immunotherapy Congress in San Diego later this month we ...

In November 2022 the results of the AELIX-002 trial were published in Nature by collaborators from Aelix Therapeutics ...

WHO launched a strategy to “respond to the urgent problem of antimalarial drug resistance in Africa”. This coincided ...

As we look forward to future events, a conversation with Dr Andrew Vaillant links our event in Barcelona ...

In a study, researchers collaborated to demonstrate “clinically meaningful and statistically significant extension of survival” for patients ...

While we were in Barcelona this year for the World Vaccine Congress 2022 we had the exciting opportunity ...

In November 2022 the WHO, with “financial support” from USAID, finalised a project on vaccine safety monitoring in ...

Reported by Epicentre, a group “embedded” in Médecins sans frontières (MSF), progress is being made in a joint ...

In November 2022 the WHO shared its Global Market Vaccine Report for the year 2022. It is the ...

A study by researchers led by the University of Houston demonstrates potential to eliminate the high caused by ...

“Pioneering a new era of human health”, scientists at the Human Immune Project are tackling “one of the ...

A study in JAMA Oncology in November 2022 suggests that researchers in the US are making progress with ...

In November 2022 CEPI and the University of California, Davis announced a partnership agreement to “advance and expand ...

Another highlight from this year's World Vaccine Congress in Europe was the opportunity to speak to Dr Christian ...

On 8th November 2022 the WHO and the 5 members of the World Health Professions Alliance (WHPA) signed ...

A publication in October 2022 by researchers at LUMC investigated the safety and immunogencity of ISA therapeutic vaccine ...

As we continue sharing interviews that took place during the World Vaccine Congress in Europe 2022 we are ...

A November press release from GSK indicates a rise and revenue in profit, attributed to its Shingrix vaccine ...

A study by researchers at the University of Portsmouth in Vaccine at the end of October explored the ...

Researchers in Europe published results in Cancer Discovery in November 2022 that indicate promising responses to vaccination with ...

Over a month after the declaration of an Ebola outbreak in Uganda in September 2022 the WHO, CEPI, ...

From the start of the COVID-19 pandemic it was clear that each of us would have a different ...

In November 2022 a commentary in The Lancet Global Health reflected that COVID-19 vaccination programmes have been “relatively ...

Migraines affect an estimated 10% of people worldwide, causing severe headaches and other symptoms such as light sensitivity, ...

In the aftermath of the World Vaccine Congress in Europe 2022 we are delighted to present the second ...

According to a study in Frontiers in Veterinary Science in October 2022, an oral vaccination study in honeybees ...

In October 2022 Sanofi and Dassault Systemes announced a partnership to optimise Sanofi’s “EVolutive Facilities” (EVF). These are ...

In October 2022 the WHO published a report that highlights the “first-ever” list of fungal priority pathogens. This ...

The UN Office for the Coordination of Humanitarian Affairs (OCHA) reported in October 2022 that UNICEF had delivered ...

The Institut Pasteur de Dakar in Senegal announced in October 2022 that it was creating a new vaccine ...

The 24th of October 2022 was World Polio Day, which draws attention to the continued global fight against ...

After security measures against avian flu were lifted in Great Britain in August 2022 the outbreak has continued ...

Dr Berkley, CEO of Gavi, the global alliance pursuing vaccine equity, wrote in the Financial Times in October ...

As Uganda’s Ebola outbreak continues to claim lives the need for a vaccine grows greater. The outbreak was ...

In October 2022 the WHO announced the renewal of a strategic Collaboration Agreement with the International Innovation Alliance ...

First detected in East Africa in the early 1900s, ASF has a high mortality rate in domestic pigs. ...

The WHO announced in October 2022 that the International Coordinating Group on Vaccine Provision will “suspend” its standard ...

After a fantastic few days at the World Vaccine Congress we at Vaccine Nation are just getting our ...

Original efforts for Polio eradication have been unsuccessful. Gavi reports that it was “supposed to be eradicated 22 ...

In October 2022 the WHO, as part of a wider Quadripartite, launched a One Health Joint Plan of ...

In October 2022 the health analytics specialist Airfinity predicted that the COVID-19 vaccine market will generate $60 billion ...

Speaking to Laura Kuenssberg of the BBC, Professors Sahin and Tureci indicated that mRNA treatments against cancers could ...

In a press release on 13th October 2022 GSK plc announced “positive pivotal phase III trial results” for ...

An article in Nature suggested that “in the wake” of the COVID-19 pandemic and consequences, an increase in ...

Japan’s Strategic Centre of Biomedical Advanced Vaccine Research and Development for Preparedness and Response SCARDA announced investment ...

An article in the New York Times in October 2022 reflects that developing a cancer vaccine for high-risk ...

A German study published in September 2022 supports “periodic low-dose intramuscular administration” of an mRNA-based therapy against Hereditary ...

In October 2022 a group of researchers from the University of Oxford reported the effects of the UK’s ...

Research published in BMJ Medicine in August 2022 reflected a collaboration to investigate the effects of COVID-19 vaccination ...

A 2022 study by the US National Foundation for Infectious Diseases found that “most adults believe annual flu ...

In October 2022 CEP and the Dutch vaccine developer Intravacc announced funding to for broad protection against variants ...

A study from the University of Oxford, published in the Journal of Applied Physiology in September 2022 investigated ...

During the COVID-19 pandemic the stark inequalities of our world were highlighted by disparities in vaccine development, production, ...

In October 2022 the Financial Times reported that Moderna had refused China’s request for the intellectual property behind ...

The Centenary Institute in Sydney and the University of Sydney announced in September that they had been awarded ...

In September 2022 Gavi reported a second consecutive year of decreased routine immunisation across 57 countries. However, early ...

Results published in Microbiology Spectrum by researchers from the US demonstrate that their Zika vaccine technology is safe ...

Vaxxas announced in September 2022 that it will receive an AU$8.2 million grant from the Australian Federal Government ...

In March 2021 the Centre for Countering Digital Hate (CCDH) published a report that identified “leading online anti-vaxxers". ...

In September 2022 the Bill & Melinda Gates Foundation announced its investment in the “development and accessibility” of ...

29th September will be World Heart Day 2022. This is a day of attention to how we can ...

Experts have warned that an early and sustained wave of flu will hit the United Kingdom this year ...

Several our recent articles have focused on the role of vaccination in cancer therapies. Initially we considered some ...

28th September 2022 is World Rabies Day, with this year’s theme being “One Health, Zero Deaths”. To mark ...

In an interview with Pharma Logistics IQ, Sanofi’s Ken Wong spoke to Leila Hawkins about the opportunities that ...

In an interview for the Human Vaccines Project in September 2022, Kristen Jill Abboud spoke to Professor Deepta ...

Here at the World Vaccine Congress, we are looking forward to our next event in Barcelona in October ...

In September 2022 the WHO announced its recommendation for the viral composition of influenza vaccines for the 2023 ...

With just a few weeks left until the World Vaccine Congress we are looking forward to hearing from ...

In September 2022 the Sabin Vaccine Institute announced that it was “receiving an additional $21.8 million” from the ...

An article by Gavi in September 2022 explored the few studies that investigate the links between COVID-19 vaccination ...

In September the US hosted a “pledging conference” for the Global Fund to Fight AIDS, Tuberculosis, and Malaria. ...

In September 2022 the WHO announced that health authorities in Uganda had declared an outbreak of Ebola. This ...

In September 2022 CEPI announced the launch of its second phase of funding to “advance innovative Rift Valley ...

In a white paper from SGS in September 2022 the importance of “analytical biosafety testing” and “advances in ...

In September 2022 LABIOTECH.EU announced that a partnership between European biotech companies had been awarded a €1.06 million ...

Dr Anthony Fauci warned that tension caused by the politicisation of the COVID-19 vaccination programme could affect routine ...

In September 2022 Biden declared in a 60 Minutes broadcast that the “pandemic is over”. Despite acknowledging that ...

On September 17th the WHO marks World Patient Safety Day: safe maternal and new-born care. The World Health ...

Published in Nature in September 2022, Ken Garber explores the hopes of mRNA companies who are setting their ...

In Nature in September 2022 an article by Anthony King identified the difficulties associated with creating an immunotherapy ...

In its 23rd year the World Vaccine Congress Europe is set to be one of our biggest and ...

In September the US HHS announced it was “significantly expanding the number of locations nationwide that can be ...

The WHO Director General reflected in his weekly press conference in early September that the end of the COVID-19 ...

The WHO reported in 2021 that pneumonia accounted for 14% of all deaths of children under 5, the ...

Pfizer announced in September 2022 that the first participants in its “pivotal” Phase III influenza trial had been ...

Genexine, a Korean biopharmaceutical company, announced in August that its “first-in-class proprietary DNA vaccine” demonstrated efficacy and safety ...

Q Fever, or ‘Query’ fever, was first identified in Australia in the 1930s as workers at a meat ...

At the end of August 2022, PharmaJet announced that the WHO had chosen its Tropis Needle-free Injection System ...

An article by Professor Hotez in Trends in Pharmacological Sciences in September 2022 explored the demand and potential ...

The Financial Times warned in September that health experts in the US were concerned about the COVID-19 booster ...

It is well-known that the need to develop vaccines, or rather a vaccine, against future iterations of COVID-19, ...

NIAID announced in September 2022 that a clinical trial “evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine” ...

HIV is widely considered to present the scientific community with a “daunting scientific challenge”, as stated by Dr ...

Pfizer announced in September 2022 that its investigational Group B Streptococcus vaccine candidate, GBS6, had received Breakthrough Therapy ...

Results published in The Lancet Infectious Diseases in September 2022 demonstrated “high efficacy” for a booster vaccine against ...

An article in In Vivo explored the potential of OVs, crediting “relatively safe mode of action” and possibility ...

We hear from Professor Carlos Guzman, head of Vaccinology and Applied Microbiology at the Helmholtz Centre for Infection ...

At the 23rd IUSTI World Congress in September 2022 the first online portal on vaccine development for sexually ...

In early September 2022 CanSino Biologics Inc. announced that the National Medical Products Administration of China (NMPA) had ...

In a previous article on the mysterious “tomato flu” or “tomato fever” in Kerala, India, we explored how ...

On 30th August the Ministry of Health in Argentina informed the WHO/PAHO that it had been notified of ...

The Cumming Global Centre for Pandemic Therapies (CGCPT) launched on 31st August 2022, thanks to a donation of ...

WHO Director General Dr Tedros Adhanom Ghebreyesus announced on 31st August that the WHO had classified current flooding ...

In August 2022 UK health agencies had to clarify that the recommendation for covid vaccination during pregnancy has ...

IAVI announced in August 2022 that volunteers for the PREVAIL clinical trial have been vaccinated with a novel ...

Africa’s Centre for Disease Control and Prevention suggests that less than 1% of the vaccines used in Africa ...

The European Vaccine Initiative, working with VACCELERATE partners, published findings of an “Inventory and gap analysis report of ...

Researchers from the Technicon-Israel Institute of Technology and Sheba Medical Centre published in the Journal for ImmunoTherapy of ...

In August 2022 Dr Hans Henri P Kluge, WHO Regional Director for Europe, outlined three actions on three ...

In August 2022 an article for NAM’s Aidsmap detailed the approval of Gilead Sciences’ long-acting HIV capsid inhibitor ...

Following Moderna’s announcement that it would be filing patent infringement lawsuits against Pfizer and BioNTech, the two companies ...

Indonesia’s National Agency for Drug and Food Control approved Takeda’s dengue vaccine candidate in August 2022. The vaccine, ...

Moderna announced that it was filing lawsuits against Pfizer and BioNTech. On 26th August, Moderna suggested that the ...

Pfizer announced that the Phase III clinical trial of RENOIR demonstrated “positive data”. RSV vaccine Efficacy iN Older ...

As India grapples with a “probable emergence of fourth wave” of Covid-19, a new virus has entered the ...

In an article published in August 2022 researchers from Europe proposed “GREENER” criteria for reducing the effects of ...

The US President Joe Biden announced in February his intention to reignite his 2016 Cancer Moonshot mission. The ...

The WHO announced in August that the National Medical Products Administration (NMPA) has achieved maturity level three (ML3) ...

The UK Health Security Agency (UKHSA) reminded university students to ensure their vaccinations are up to date before ...

HDT Bio, a developer of immunotherapies for oncology and infectious diseases, announced in August 2022 that it is ...

A group of researchers at the University of Oxford are investigating the therapeutic potential of an antiviral called ...

In August 2022 Valneva SE, a speciality vaccine company based in France, announced that it has “initiated rolling ...

A report by DefeatDD, which aims to address the issues caused by diarrhoea, comments that “the day we ...

The Australian Centre for International Agricultural Research (ACIAR) and Canada’s International Development Research Centre (IDRC) have come together ...

A study in Nature Communications in August 2022 presented an investigation by researchers at Oxford University. They explored ...

The WHO published its first guideline for Ebola virus disease therapeutics in August 2022, coinciding with a reported ...

A study published in Nature stated that research into curing HIV focuses on “reactivating latent proviruses to enable ...

In its 23rd year the World Vaccine Congress Europe is set to be one of our biggest and ...

The pharmaceutical company GSK was awarded a contract for the first supply of a malaria vaccine by UNICEF ...

The beginning of Malawi’s cholera outbreak in March 2022 came at the end of rainy season. A spokesperson ...

Bavarian Nordic announced in August 2022 that it had “entered into an agreement” with GRAM to expand capacity ...

UNITAID published a report to examine the "tools and interventions” to prevent mother-to-child transmission of HIV, syphilis, hepatitis ...

The European Scientific Counsel Companion Animal Parasites called for compulsory testing of imported dogs after the UK’s first ...

In August 2022 the WHO announced new guidance to “support national strategic planning” for TB responses. This guidance ...

In August 2022 the Joint Committee on Vaccination and Immunisation (JCVI) published advice on the boosters that will ...

In a white paper for IDT Biologika Dr Heidi Trusheim and Trevor Broadt examine the process of developing ...

A study in PNAS in August 2022 presented an mRNA vaccine for cancer that targets the lymph nodes ...

The UK’s Chief Veterinary Office, Professor Christine Middlemiss, is appealing to bird keepers to maintain enhanced biosecurity measures. ...

The UK Medicines and Healthcare products regulatory Agency (MHRA) announced in August that it had approved Moderna’s bivalent ...

Researchers announced in August 2022 that they found evidence that the drug terazosin “protects against the death of ...

In a white paper Dr Neubert explores how viral vectors offer a host of opportunities for vaccine development ...

A study published in The Lancet in August 2022 concluded that Covid-19 vaccinations had a “good safety profile”. ...

In July CEPI announced that it would provide $375,000 to “support the development of key laboratory tools to ...

In August 2022 Dr Peter Hotez wrote an article in Nature exploring the dire consequences of America’s “anti-vaccine ...

Langya (LayV) is a henipavirus. According to an article in New Scientist it appears to be “most closely ...

As monkeypox cases across the world continue to increase, rollouts of the one licensed vaccine are under pressure. ...

When providing an immune response to cancer T-cells are known to get “exhausted” to the point of no ...

Scientists at La Jolla Institute for immunology have concluded that patients with a stronger immune response to the ...

Malaria threatens almost half of the world’s population, with the WHO estimating that the number of deaths in ...

The WHO states that cancer is a “leading cause of death worldwide”. It accounted for nearly 1 in ...

In August 2022 a study published in Nature concluded that 58% of infectious diseases that we face have ...